Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication

Clinical Trial Grant

Administered By

School of Medicine

Awarded By

Alnylam Pharmaceuticals

Start Date

May 26, 2022

End Date

December 31, 2026
 

Administered By

School of Medicine

Awarded By

Alnylam Pharmaceuticals

Start Date

May 26, 2022

End Date

December 31, 2026